The roles of estrogen and estrogen receptors in gastrointestinal disease (Review)
- Authors:
- Changmei Chen
- Xiang Gong
- Xiaoxu Yang
- Xianhui Shang
- Qian Du
- Qiushi Liao
- Rui Xie
- Yuanshou Chen
- Jingyu Xu
-
Affiliations: Department of Gastroenterology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China, Institute of Burns, Tongren Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China, Department of Pediatric Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China, Department of Physiology, Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China - Published online on: October 11, 2019 https://doi.org/10.3892/ol.2019.10983
- Pages: 5673-5680
This article is mentioned in:
Abstract
 |
 |
 |
|
Simpson ER: Sources of estrogen and their importance. J Steroid Biochem Mol Biol. 86:225–230. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Guyton AC and Hall J: Guyton and Hall Textbook of Medical Physiology. 957–999. 2011. | |
|
Nilsson S and Gustafsson JA: Estrogen receptors: Therapies targeted to receptor subtypes. Clin Pharmacol Ther. 89:44–55. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Labrie F: Extragonadal synthesis of sex steroids: Intracrinology. Ann Endocrinol (Paris). 64:95–107. 2003.PubMed/NCBI | |
|
Kim YS, Kim N and Kim GH: Sex and gender differences in gastroesophageal reflux disease. J Neurogastroenterol Motil. 22:575–588. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kurt D, Saruhan BG, Kanay Z, Yokus B, Kanay BE, Unver O and Hatipoglu S: Effect of ovariectomy and female sex hormones administration upon gastric ulceration induced by cold and immobility restraint stress. Saudi Med J. 28:1021–1027. 2007.PubMed/NCBI | |
|
Meleine M and Matricon J: Gender-related differences in irritable bowel syndrome: Potential mechanisms of sex hormones. World J Gastroenterol. 20:6725–6743. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Batistatou A, Stefanou D, Goussia A, Arkoumani E, Papavassiliou AG and Agnantis NJ: Estrogen receptor beta (ERbeta) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasm. J Cancer Res Clin Oncol. 130:405–410. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Yang H, Sukocheva OA, Hussey DJ and Watson DI: Estrogen, male dominance and esophageal adenocarcinoma: Is there a link? World J Gastroenterol. 18:393–400. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M and Gustafsson JA: Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab. 82:4258–4265. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Rochira V, Granata AR, Madeo B, Zirilli L, Rossi G and Carani C: Estrogens in males: What have we learned in the last 10 years? Asian J Androl. 7:3–20. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Strom A, Treuter E, Warner M and Gustafsson JA: Estrogen receptors: How do they signal and what are their targets. Physiol Rev. 87:905–931. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Carmeci C, Thompson DA, Ring HZ, Francke U and Weigel RJ: Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics. 45:607–617. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Filardo EJ and Thomas P: Minireview: G protein-coupled estrogen receptor-1, GPER-1: Its mechanism of action and role in female reproductive cancer, renal and vascular physiology. Endocrinology. 153:2953–2962. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Sanden C, Broselid S, Cornmark L, Andersson K, Daszkiewicz-Nilsson J, Martensson UE, Olde B and Leeb-Lundberg LM: G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments. Mol Pharmacol. 79:400–410. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Filardo EJ, Quinn JA, Bland KI and Frackelton AR Jr: Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol. 14:1649–1660. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Revankar CM, Cimino DF, Sklar LA, Arterburn JB and Prossnitz ER: A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 307:1625–1630. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Thomas P, Pang Y, Filardo EJ and Dong J: Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 146:624–632. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma G and Prossnitz ER: G-protein-coupled estrogen receptor (GPER) and sex-specific metabolic homeostasis. Adv Exp Med Boil. 1043:427–453. 2017. View Article : Google Scholar | |
|
Vakil N, van Zanten SV, Kahrilas P, Dent J and Jones R; Globale Konsensusgruppe, : The Montreal definition and classification of gastroesophageal reflux disease: A global, evidence-based consensus paper. Z Gastroenterol. 45:1125–1140. 2007.(Article in German). View Article : Google Scholar : PubMed/NCBI | |
|
Katzka DA, Pandolfino JE and Kahrilas PJ: Phenotypes of gastroesophageal reflux disease: Where rome, lyon, and montreal meet. Clin Gastroenterol Hepatol. July 15–2019.(Epub ahead of print). View Article : Google Scholar | |
|
Nam SY, Choi IJ, Ryu KH, Park BJ, Kim YW, Kim HB and Kim JS: The effect of abdominal visceral fat, circulating inflammatory cytokines, and leptin levels on reflux esophagitis. J Neurogastroenterol Motil. 21:247–254. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Pohl H, Wrobel K, Bojarski C, Voderholzer W, Sonnenberg A, Rosch T and Baumgart DC: Risk factors in the development of esophageal adenocarcinoma. Am J Gastroenterol. 108:200–207. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Asanuma K, Iijima K and Shimosegawa T: Gender difference in gastro-esophageal reflux diseases. World J Gastroenterol. 22:1800–1810. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Iijima K and Shimosegawa T: Involvement of luminal nitric oxide in the pathogenesis of the gastroesophageal reflux disease spectrum. J Gastroenterol Hepatol. 29:898–905. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Masaka T, Iijima K, Endo H, Asanuma K, Ara N, Ishiyama F, Asano N, Koike T, Imatani A and Shimosegawa T: Gender differences in oesophageal mucosal injury in a reflux oesophagitis model of rats. Gut. 62:6–14. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Boeckxstaens G, El-Serag HB, Smout AJ and Kahrilas PJ: Symptomatic reflux disease: The present, the past and the future. Gut. 63:1185–1193. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Jacobson BC, Moy B, Colditz GA and Fuchs CS: Postmenopausal hormone use and symptoms of gastroesophageal reflux. Arch Intern Med. 168:1798–1804. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Van Thiel DH, Gavaler JS and Stremple J: Lower esophageal sphincter pressure in women using sequential oral contraceptives. Gastroenterology. 71:232–234. 1976. View Article : Google Scholar : PubMed/NCBI | |
|
Nilsson M, Lundegardh G, Carling L, Ye W and Lagergren J: Body mass and reflux oesophagitis: An oestrogen-dependent association? Scand J Gastroenterol. 37:626–630. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Nilsson M, Johnsen R, Ye W, Hveem K and Lagergren J: Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 290:66–72. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Nordenstedt H, Zheng Z, Cameron AJ, Ye W, Pedersen NL and Lagergren J: Postmenopausal hormone therapy as a risk factor for gastroesophageal reflux symptoms among female twins. Gastroenterology. 134:921–928. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
el-Serag HB: The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am. 31421–440. (viii)2002. View Article : Google Scholar : PubMed/NCBI | |
|
Vizcaino AP, Moreno V, Lambert R and Parkin DM: Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995. Int J Cancer. 99:860–868. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Mathieu LN, Kanarek NF, Tsai HL, Rudin CM and Brock MV: Age and sex differences in the incidence of esophageal adenocarcinoma: Results from the surveillance, epidemiology, and end results (SEER) registry (1973–2008). Dis Esophagus. 27:757–763. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang BJ, Zhang B, Yan SS, Li ZC, Jiang T, Hua CJ, Lu L, Liu XZ, Zhang DH, Zhang RS and Wang X: Hormonal and reproductive factors and risk of esophageal cancer in women: A meta-analysis. Dis Esophagus. 29:448–454. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wang QM, Qi YJ, Jiang Q, Ma YF and Wang LD: Relevance of serum estradiol and estrogen receptor beta expression from a high-incidence area for esophageal squamous cell carcinoma in China. Med Oncol. 28:188–193. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Z, He Q, Fu S and Zheng Z: Estrogen receptors in regulating cell proliferation of esophageal squamous cell carcinoma: Involvement of intracellular Ca(2+) signaling. Pathol Oncol Res. 23:329–334. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Hennessy BA, Harvey BJ and Healy V: 17beta-Estradiol rapidly stimulates c-fos expression via the MAPK pathway in T84 cells. Mol Cell Endocrinol. 229:39–47. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Zuguchi M, Miki Y, Onodera Y, Fujishima F, Takeyama D, Okamoto H, Miyata G, Sato A, Satomi S and Sasano H: Estrogen receptor α and β in esophageal squamous cell carcinoma. Cancer Sci. 103:1348–1355. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Ueo H, Matsuoka H, Sugimachi K, Kuwano H, Mori M and Akiyoshi T: Inhibitory effects of estrogen on the growth of a human esophageal carcinoma cell line. Cancer Res. 50:7212–7215. 1990.PubMed/NCBI | |
|
Menon S, Nightingale P and Trudgill N: Is hormone replacement therapy in post-menopausal women associated with a reduced risk of oesophageal cancer? United European Gastroenterol J. 2:374–382. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lanas A and Chan FKL: Peptic ulcer disease. Lancet. 390:613–624. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kanotra R, Ahmed M, Patel N, Thakkar B, Solanki S, Tareen S, Fasullo MJ, Kesavan M, Nalluri N, Khan A, et al: Seasonal variations and trends in hospitalization for peptic ulcer disease in the United States: A 12-year analysis of the nationwide inpatient sample. Cureus. 8:e8542016.PubMed/NCBI | |
|
Suleyman H, Albayrak A, Bilici M, Cadirci E and Halici Z: Different mechanisms in formation and prevention of indomethacin-induced gastric ulcers. Inflammation. 33:224–234. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Feldman M, Richardson CT and Walsh JH: Sex-related differences in gastrin release and parietal cell sensitivity to gastrin in healthy human beings. J Clin Invest. 71:715–720. 1983. View Article : Google Scholar : PubMed/NCBI | |
|
Sangma TK, Jain S and Mediratta PK: Effect of ovarian sex hormones on non-steroidal anti-inflammatory drug-induced gastric lesions in female rats. Indian J Pharmacol. 46:113–116. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Okada K, Inamori M, Imajyo K, Chiba H, Nonaka T, Shiba T, Sakaguchi T, Atsukawa K, Takahashi H, Hoshino E and Nakajima A: Gender differences of low-dose aspirin-associated gastroduodenal ulcer in Japanese patients. World J Gastroenterol. 16:1896–1900. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Speir E, Yu ZX, Takeda K, Ferrans VJ and Cannon RO III: Antioxidant effect of estrogen on cytomegalovirus-induced gene expression in coronary artery smooth muscle cells. Circulation. 102:2990–2996. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang F and Shen X: Current prevalence status of gastric cancer and recent studies on the roles of circular RNAs and methods used to investigate circular RNAs. Cell Mol Biol Lett. 24:532019. View Article : Google Scholar : PubMed/NCBI | |
|
Chung HW, Noh SH and Lim JB: Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea. World J Gastroenterol. 16:256–263. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Tokunaga A, Kojima N, Andoh T, Matsukura N, Yoshiyasu M, Tanaka N, Ohkawa K, Shirota A, Asano G and Hayashi K: Hormone receptors in gastric cancer. Eur J Cancer Clin Oncol. 19:687–689. 1983. View Article : Google Scholar : PubMed/NCBI | |
|
Lindblad M, Ye W, Rubio C and Lagergren J: Estrogen and risk of gastric cancer: A protective effect in a nationwide cohort study of patients with prostate cancer in Sweden. Cancer Epidemiology Biomarkers Prev. 13:2203–2207. 2004. | |
|
Furukawa H, Iwanaga T, Koyama H and Taniguchi H: Effect of sex hormones on the experimental induction of cancer in rat stomach-a preliminary study. Digestion. 23:151–155. 1982. View Article : Google Scholar : PubMed/NCBI | |
|
Kim MJ, Cho SI, Lee KO, Han HJ, Song TJ and Park SH: Effects of 17β-estradiol and estrogen receptor antagonists on the proliferation of gastric cancer cell lines. J Gastric Cancer. 13:172–178. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chandanos E and Lagergren J: Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer. 44:2397–2403. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Sunakawa Y, Cao S, Berger MD, Matsusaka S, Yang D, Zhang W, Ning Y, Parekh A, Stremitzer S, Mendez A, et al: Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer. Pharmacogenomics J. 17:36–41. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Matsuyama S, Ohkura Y, Eguchi H, Kobayashi Y, Akagi K, Uchida K, Nakachi K, Gustafsson JA and Hayashi S: Estrogen receptor beta is expressed in human stomach adenocarcinoma. J Cancer Res Clin Oncol. 128:319–324. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Takano N, Iizuka N, Hazama S, Yoshino S, Tangoku A and Oka M: Expression of estrogen receptor-alpha and -beta mRNAs in human gastric cancer. Cancer Lett. 176:129–135. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Wang M, Pan JY, Song GR, Chen HB, An LJ and Qu SX: Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: Correlation with prothymosin alpha and clinicopathological parameters. Eur J Surg Oncol. 33:195–201. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ryu WS, Kim JH, Jang YJ, Park SS, Um JW, Park SH, Kim SJ, Mok YJ and Kim CS: Expression of estrogen receptors in gastric cancer and their clinical significance. J Surg Oncol. 106:456–461. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Qin J, Liu M, Ding Q, Ji X, Hao Y, Wu X and Xiong J: The direct effect of estrogen on cell viability and apoptosis in human gastric cancer cells. Mol Cell Biochem. 395:99–107. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang BG, Du T, Zang MD, Chang Q, Fan ZY, Li JF, Yu BQ, Su LP, Li C, Yan C, et al: Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9. Oncotarget. 5:10584–10595. 2014.PubMed/NCBI | |
|
Wesolowska M, Pawlik P and Jagodzinski PP: The clinicopathologic significance of estrogen receptors in human gastric carcinoma. Biomed Pharmacother. 83:314–322. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou J, Teng R, Xu C, Wang Q, Guo J, Xu C, Li Z, Xie S, Shen J and Wang L: Overexpression of ERα inhibits proliferation and invasion of MKN28 gastric cancer cells by suppressing β-catenin. Oncol Rep. 30:1622–1630. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Deng H, Zou F, Fu Z, Chen Y, Wang Z and Liu L: ER-α36-mediated gastric cancer cell proliferation via the c-Src pathway. Oncol Lett. 6:329–335. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tang W, Liu R, Yan Y, Pan X, Wang M, Han X, Ren H and Zhang Z: Expression of estrogen receptors and androgen receptor and their clinical significance in gastric cancer. Oncotarget. 8:40765–40777. 2017.PubMed/NCBI | |
|
Wakui S, Motohashi M, Muto T, Takahashi H, Hano H, Jutabha P, Anzai N, Wempe MF and Endou H: Sex-associated difference in estrogen receptor β expression in N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric cancers in rats. Comp Med. 61:412–418. 2011.PubMed/NCBI | |
|
Choung RS and Locke GR III: Epidemiology of IBS. Gastroenterol Clin North Am. 40:1–10. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Heitkemper M, Jarrett M, Bond EF and Chang L: Impact of sex and gender on irritable bowel syndrome. Biol Res Nurs. 5:56–65. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Longstreth GF and Wolde-Tsadik G: Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates. Dig Dis Sci. 38:1581–1589. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Toner BB and Akman D: Gender role and irritable bowel syndrome: Literature review and hypothesis. Am J Gastroenterol. 95:11–16. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Heitkemper MM and Chang L: Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? Gender Med. 2 (Suppl 6):152–167. 2009. View Article : Google Scholar | |
|
Chaloner A and Greenwood-Van Meerveld B: Sexually dimorphic effects of unpredictable early life adversity on visceral pain behavior in a rodent model. J Pain. 14:270–280. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Cao DY, Ji Y, Tang B and Traub RJ: Estrogen receptor β activation is antinociceptive in a model of visceral pain in the rat. J Pain. 13:685–694. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Jacenik D, Cygankiewicz AI, Fichna J, Mokrowiecka A, Malecka-Panas E and Krajewska WM: Estrogen signaling deregulation related with local immune response modulation in irritable bowel syndrome. Mol Cell Endocrinol. 471:89–96. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Qin B, Dong L, Guo X, Jiang J, He Y, Wang X, Li L and Zhao J: Expression of G protein-coupled estrogen receptor in irritable bowel syndrome and its clinical significance. Int J Clin Exp Pathol. 7:2238–2246. 2014.PubMed/NCBI | |
|
Zielinska M, Fichna J, Bashashati M, Habibi S, Sibaev A, Timmermans JP and Storr M: G protein-coupled estrogen receptor and estrogen receptor ligands regulate colonic motility and visceral pain. Neurogastroenterol Motil. 29:2017. View Article : Google Scholar : PubMed/NCBI | |
|
Mizoguchi A, Takeuchi T, Himuro H, Okada T and Mizoguchi E: Genetically engineered mouse models for studying inflammatory bowel disease. J Pathol. 238:205–219. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Xavier RJ and Podolsky DK: Unravelling the pathogenesis of inflammatory bowel disease. Nature. 448:427–434. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW and Kaplan GG: Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 142:46–54.e42; quiz e30. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Cook LC, Hillhouse AE, Myles MH, Lubahn DB, Bryda EC, Davis JW and Franklin CL: The role of estrogen signaling in a mouse model of inflammatory bowel disease: A Helicobacter hepaticus model. PLoS One. 9:e942092014. View Article : Google Scholar : PubMed/NCBI | |
|
Barzi A, Lenz AM, Labonte MJ and Lenz HJ: Molecular pathways: Estrogen pathway in colorectal cancer. Clin Cancer Res. 19:5842–5848. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Principi M, Barone M, Pricci M, De Tullio N, Losurdo G, Ierardi E and Di Leo A: Ulcerative colitis: From inflammation to cancer. Do estrogen receptors have a role? World J Gastroenterol. 20:11496–11504. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Pierdominici M, Maselli A, Varano B, Barbati C, Cesaro P, Spada C, Zullo A, Lorenzetti R, Rosati M, Rainaldi G, et al: Linking estrogen receptor β expression with inflammatory bowel disease activity. Oncotarget. 6:40443–40451. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Armstrong CM, Allred KF, Weeks BR, Chapkin RS and Allred CD: Estradiol has differential effects on acute colonic inflammation in the presence and absence of estrogen receptor β expression. Dig Dis Sci. 62:1977–1984. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Looijer-van Langen M, Hotte N, Dieleman LA, Albert E, Mulder C and Madsen KL: Estrogen receptor-β signaling modulates epithelial barrier function. Am J Physiol Gastrointest Liver Physiol. 300:G621–G626. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Saleiro D, Murillo G, Benya RV, Bissonnette M, Hart J and Mehta RG: Estrogen receptor-β protects against colitis-associated neoplasia in mice. Int J Cancer. 131:2553–2561. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bustos V, Nolan AM, Nijhuis A, Harvey H, Parker A, Poulsom R, McBryan J, Thomas W, Silver A and Harvey BJ: GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions. Oncotarget. 8:84258–84275. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-Bonikou G and Papavassiliou AG: Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer. 39:1251–1258. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Delellis Henderson K, Duan L, Sullivan-Halley J, Ma H, Clarke CA, Neuhausen SL, Templeman C and Bernstein L: Menopausal hormone therapy use and risk of invasive colon cancer: The california teachers study. Am J Epidemiol. 171:415–425. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, et al: Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA. 310:1353–1368. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 19:61–109. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Calle EE, Miracle-McMahill HL, Thun MJ and Heath CW Jr: Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst. 87:517–523. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Simon MS, Chlebowski RT, Wactawski-Wende J, Johnson KC, Muskovitz A, Kato I, Young A, Hubbell FA and Prentice RL: Estrogen plus progestin and colorectal cancer incidence and mortality. J Clin Oncol. 30:3983–3990. 2012. View Article : Google Scholar : PubMed/NCBI |
